These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34692635)

  • 1. Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators.
    Olson KM; Traynor JR; Alt A
    Front Chem; 2021; 9():671483. PubMed ID: 34692635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of allosteric modulators of GPCRs for treatment of CNS disorders.
    Nickols HH; Conn PJ
    Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands.
    Shpakov AO
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
    Reinecke BA; Wang H; Zhang Y
    Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of fluorescent peptide G protein-coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators.
    Farmer JP; Mistry SN; Laughton CA; Holliday ND
    FASEB J; 2022 Nov; 36(11):e22576. PubMed ID: 36183332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.
    Wang L; Martin B; Brenneman R; Luttrell LM; Maudsley S
    J Pharmacol Exp Ther; 2009 Nov; 331(2):340-8. PubMed ID: 19667132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric targeting of receptor tyrosine kinases.
    De Smet F; Christopoulos A; Carmeliet P
    Nat Biotechnol; 2014 Nov; 32(11):1113-20. PubMed ID: 25380447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous allosteric modulators of G protein-coupled receptors.
    van der Westhuizen ET; Valant C; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2015 May; 353(2):246-60. PubMed ID: 25650376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of G protein-coupled receptors.
    May LT; Avlani VA; Sexton PM; Christopoulos A
    Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric Modulators of the Class A G Protein Coupled Receptors.
    Tschammer N
    Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System.
    Xu H; Tilley DG
    J Cardiovasc Pharmacol; 2022 Sep; 80(3):378-385. PubMed ID: 35170495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled receptor allosterism and complexing.
    Christopoulos A; Kenakin T
    Pharmacol Rev; 2002 Jun; 54(2):323-74. PubMed ID: 12037145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulators targeting CNS muscarinic receptors.
    Bock A; Schrage R; Mohr K
    Neuropharmacology; 2018 Jul; 136(Pt C):427-437. PubMed ID: 28935216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.